Mechanistic insights into a thermoresponsive in situ nanoemulgel of azilsartan medoxomil for intranasal delivery: a promising nanotherapeutic approach to target dementia.
Sign Up to like & getrecommendations! Published in 2025 at "Biomaterials science"
DOI: 10.1039/d5bm00066a
Abstract: Cognitive impairment and dementia have become a global burden, distressing millions of elderly and accounting for the progressive loss of neurons in the brain, affecting multiple cortical centers. The renin-angiotensin system and its receptors, widely… read more here.
Keywords: intranasal delivery; dementia; brain; situ nanoemulgel ... See more keywords
OBSERVATIONAL PROSPECTIVE STUDY OF AZILSARTAN MEDOXOMIL/ CHLORTALIDONE COMPARED WITH IRBESARTAN/ HYDROCHLOROTHIAZIDE COMBINATION THERAPY IN OBESE HYPERTENSIVES (PUZZLE)
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Hypertension"
DOI: 10.1097/01.hjh.0000838640.69350.8f
Abstract: Objective: Attainment of blood pressure (BP) control is important to successful management of arterial hypertension (AH). It is more difficult to reach recommended BP goals in obese hypertensives. Combination of ARB and thiazide diuretics is… read more here.
Keywords: irb; combination; group; obese hypertensives ... See more keywords
Efficacy and safety of different doses of azilsartan medoxomil in patients with hypertension
Sign Up to like & getrecommendations! Published in 2019 at "Medicine"
DOI: 10.1097/md.0000000000017050
Abstract: Abstract Background: Hypertension is one of the most common chronic diseases and an increasingly public-health challenge worldwide. Previous meta-analyses evaluated the effects of azilsartan medoxomil compared to placebo or other antihypertensive drugs in patients with… read more here.
Keywords: different doses; doses azilsartan; hypertension; azilsartan medoxomil ... See more keywords
Abstract FR425: Antihypertensive Efficacy of Angiotensin Receptor Blockers with and without Inverse Agonism: A Systematic Review and Network Meta-analysis
Sign Up to like & getrecommendations! Published in 2025 at "Hypertension"
DOI: 10.1161/hyp.82.suppl_1.fr425
Abstract: Objectives: Angiotensin receptor blockers (ARBs) with inverse agonism (IA) may have potential for more blood pressure (BP) reduction as compared to ARBs without IA, while the efficacy is yet to be elucidated. Methods: A systematic… read more here.
Keywords: arbs without; receptor blockers; angiotensin receptor; azilsartan medoxomil ... See more keywords
Central Composite Design Implemented Azilsartan Medoxomil Loaded Nanoemulsion to Improve Its Aqueous Solubility and Intestinal Permeability: In Vitro and Ex Vivo Evaluation
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceuticals"
DOI: 10.3390/ph15111343
Abstract: The present research attempted to design and develop a nanoemulsion formulation of azilsartan medoxomil to improve its aqueous solubility and intestinal permeability. Based on the solubility profile, ethyl oleate, tween 80, and Transcutol P were… read more here.
Keywords: formulation; microscopy; design; azilsartan medoxomil ... See more keywords